| Literature DB >> 28597448 |
Shyh-Shyun Huang1, Shan-Yu Su2, Jui-Shu Chang3, Hung-Jen Lin2, Wen-Tzu Wu4, Jeng-Shyan Deng5, Guan-Jhong Huang6.
Abstract
BACKGROUND: The aim of this study was to examine the possible antioxidant, anti-inflammatory, and antidiabetic effects of the aqueous extracts from three Glycine species. In HPLC analysis, the chromatograms of three Glycine species were established. Flavonoid-related compounds might be important bioactive compounds in Glycine species.Entities:
Keywords: Aldose reductase; Anti-inflammatory; Antioxidant; Glycine species; α-Glucosidase
Year: 2016 PMID: 28597448 PMCID: PMC5432927 DOI: 10.1186/s40529-016-0153-7
Source DB: PubMed Journal: Bot Stud ISSN: 1817-406X Impact factor: 2.787
Fig. 1HPLC chromatogram of the aqueous of Glycine max (AGM) (a), the aqueous of Glycine tomentella (AGT) (b), and the aqueous of Glycine tabacina (AGTa) (c). The peaks indicate the following 1 daidzin; 2 genistin; 3 daidzein; 4 genistein. IS butyl p-hydroxybenzoate
Contents of total polyphenols, flavonoids, and radical scavenging activity of the aqueous extracts from three Glycine species determined by TEAC, and DPPH assay
| Species and positive controls | Total phenolsa (μg CE/mg) | Total flavonoidsb (μg RE/mg) | TEAC (μmol TE/g) | DPPH IC50 value (µg/mL) |
|---|---|---|---|---|
| AGM | 21.58 ± 0.04 | 3.86 ± 0.13 | 7.67 ± 0.04 | 378.18 |
| AGT | 76.35 ± 0.09 | 7.43 ± 0.14 | 7.76 ± 0.04 | 249.88 |
| AGTa | 94.92 ± 0.12 | 7.62 ± 0.12 | 8.47 ± 0.08 | 212.41 |
| Genistein | (−) | (−) | 32.57 ± 0.17 | 106.22 |
| Daidzein | (−) | (−) | 30.52 ± 0.33 | 90.68 |
All values expressed as mean ± SD of triplicate tests. (n = 3). Means which did not share a common letter were significantly different (p < 0.05) when analyzed by ANOVA and Ducan’s multiple-range tests
aData expressed in μg catechin equivalent/mg dry weight (μg CE/mg)
bData expressed in μg rutin equivalent/mg dry weight (μg rutin/mg)
Fig. 2Effects of three Glycine species, genistein, and daidzein on lipopolysaccharide (LPS)-induced cell viability (a) and NO production (b) of RAW 264.7 macrophages. Cells were incubated for 24 h with 100 ng/mL of LPS in the absence or presence of three Glycine species (0, 62.5, 125, 250, 500 and 1000 μg/mL), genistein, or daidzein (5 and 10 μg/mL). Samples were added 1 h before incubation with LPS. Cell viability assay was performed using MTT assay. Nitrite concentration in the medium was determined using Griess reagent. The data were presented as mean ± SD for three different experiments performed in triplicate. ###Compared with sample of control group. *p < 0.05 and **p < 0.01 were compared with LPS-alone group
Fig. 3Inhibition of iNOS and COX-2 protein expression by three Glycine species in LPS-stimulated RAW264.7 cells. Cells were incubated for 24 h with 100 μg/mL of LPS in the absence or the presence of three Glycine species (0, 125 and 250 μg/mL). Samples were added 1 h before incubation with LPS. Lysed cells were then prepared and subjected to western blotting using an antibody specific for iNOS and COX-2 (a). The values under each lane indicate the relative band intensities normalized to β-actin (b). β-actin was used as a quantity control. The data were presented as mean ± SD for three different experiments performed in triplicate
Fig. 4Inhibition of iNOS and COX-2 protein expression by genistein and daidzein in LPS-stimulated RAW264.7 cells. Cells were incubated for 24 h with 100 μg/mL of LPS in the absence or the presence of genistein or daidzein (5 and 10 μg/mL). Samples were added 1 h before incubation with LPS. Lysed cells were then prepared and subjected to Western Blotting using an antibody specific for iNOS and COX-2 (a). The values under each lane indicate the relative band intensities normalized to β-actin (b). β-actin was used as a quantity control. The data were presented as mean ± SD for three different experiments performed in triplicate
Inhibitory effect of the aqueous extracts from three Glycine species on the α-glucosidase and aldose reductase inhibition
| Species and positive controls | α-Glucosidase inhibitor IC50 value (µg/mL) | Aldose reductase inhibitor IC50 value (µg/mL) |
|---|---|---|
| AGM | 405.83 | 244.81 |
| AGT | 211.17 | 148.98 |
| AGTa | 188.1 | 126.42 |
| Acarbose | 517.98 | N.D.a |
| Genistein | 20.91 | 42.52 |
| Daidzein | 13.69 | 31.95 |
Values represented mean ± SD of three parallel measurements
a N.D. not detected